VJHemOnc is committed to improving our service to you

COSTEM 2019 | Is haploidentical the best curative option for sickle cell disease?

VJHemOnc is committed to improving our service to you

Miguel Abboud

Miguel Abbout, MD, American University of Beirut, Beirut, Lebanon, evaluates whether haploidentical stem cell transplantation is the best curative option for sickle cell disease at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter